Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
European Review for Medical and Pharmacological Sciences|April 8, 2021
Worse impact of second wave COVID-19 pandemic in adults but not in children with inflammatory bowel disease: an Italian single tertiary center experienceS Carparelli, M R Pastore, M R Valvano, et al.
Surgical Endoscopy|November 19, 2004
Assessment of pulmonary function in patients before and after laparoscopic and open esophagogastric surgeryE Crema, A G Benelli, A V Silva, et al.
Diabetes Care|February 1, 1995
Effects of personality on metabolic control in IDDM patientsA Orlandini, M R Pastore, A Fossati, et al.
Diabetologia|July 1, 1995
Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivityE Bonifacio, S Genovese, S Braghi, et al.
Frontiers in Immunology|October 20, 2022
CD18 controls the development and activation of monocyte-to-macrophage axis during chronic schistosomiasisCamila O S Souza, Jefferson Elias-Oliveira, Marcella R Pastore, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Reproducibility and Reliability of Spectralis II OCT Angiography Vascular MeasurementsMarco R Pastore, Alberto Grotto, Francesca Vezzoni, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 19, 2016
Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysisC A Bittencourt, R Dos Santos Simões, W M Bernardo, et al.
Acta Diabetologica|July 14, 2001
Postabsorptive muscle protein metabolism in type 1 diabetic patients after pancreas transplantationL Luzi, L Piceni Sereni, M Spessot, et al.
Diabetologia|May 29, 2025
Prevention of diabetic ketoacidosis in relatives screened for islet autoantibodies and followed up in the TrialNet Pathway to Prevention study at a single institution in ItalySabina Martinenghi, Aurora Merolla, Pauline Grogan, et al.
Retina (Philadelphia, Pa.)|December 5, 2019
VITREOUS PROSTAGLANDIN E2 CHANGES AFTER TOPICAL ADMINISTRATION OF DICLOFENAC 0.1%, INDOMETHACIN 0.5%, NEPAFENAC 0.3%, AND BROMFENAC 0.09Marco R Pastore, Chiara De Giacinto, Gabriella Cirigliano, et al.
Pageof 9